Israel Englander’s NanoViricides NNVC Stock Holding History

Israel Englander’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-53,773	Closed	-$63K	–	6509
2023 Q1	$63K	Sell	53,773 -13,573	-20%	-$18.3K	﹤0.01%	5555
2022 Q4	$75K	Buy	67,346 +25,012	+59%	+$39K	﹤0.01%	5664
2022 Q3	$73K	Buy	+42,334	New	+$92.3K	﹤0.01%	6071
2021 Q1	–	Sell	-21,691	Closed	-$62K	–	6337
2020 Q4	$62K	Buy	+21,691	New	+$79K	﹤0.01%	5075
2019 Q1	–	Sell	-667	Closed	-$3K	–	4213
2018 Q4	$3K	Buy	+667	New	+$4.27K	﹤0.01%	3689
2016 Q3	–	Sell	-2,277	Closed	-$73K	–	3501
2016 Q2	$73K	Sell	2,277 -773	-25%	-$28.2K	﹤0.01%	3053
2016 Q1	$134K	Buy	3,050 +1,392	+84%	+$54K	﹤0.01%	3034
2015 Q4	$39K	Sell	1,658 -5,687	-77%	-$136K	﹤0.01%	3326
2015 Q3	$175K	Buy	7,345 +1,321	+22%	+$35K	﹤0.01%	3156
2015 Q2	$208K	Buy	+6,024	New	+$229K	﹤0.01%	3034
2014 Q3	–	Sell	-793	Closed	-$67K	–	3902
2014 Q2	$67K	Buy	+793	New	+$56.3K	﹤0.01%	3287

Other funds holding NNVC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CLOS

Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Israel Englander's NNVC Position: Q2 2023 in Review

Israel Englander sold out of NanoViricides (NNVC) in Q2 2023, closing a stake of 53,773 shares — an estimated $63K sold.

Israel Englander first reported a position in NNVC in Q2 2014 and held it in 11 quarters. The position peaked at $208K in Q2 2015. 27 funds tracked by Wall St. Rank hold NNVC as of Q2 2023.

Israel Englander reported no remaining NanoViricides position as of Q2 2023 after selling out during the quarter.
Israel Englander sold 53,773 NanoViricides shares in Q2 2023, an estimated $63K.
Israel Englander first reported a position in NanoViricides in Q2 2014 and held it in 11 quarters.
Israel Englander's NanoViricides position peaked at $208K in Q2 2015.
27 funds tracked by Wall St. Rank held NanoViricides as of Q2 2023.

Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.